SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-16-009193
Filing Date
2016-04-26
Accepted
2016-04-26 19:08:38
Documents
1
Period of Report
2016-04-25

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 6653
  Complete submission text file 0001493152-16-009193.txt   8288
Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130
Business Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130 858-704-4042
Imprimis Pharmaceuticals, Inc. (Issuer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 437 S HWY 101 STE 209 SOLANA BEACH CA 92075
Business Address
BOLL ANDREW R. (Reporting) CIK: 0001542150 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35814 | Film No.: 161593035